Preliminary experiments show conolidine may inhibit distinct ion channels, minimizing neuronal excitability and restricting discomfort indicators. This mechanism is particularly relevant in neuropathic suffering, in which irregular signaling causes persistent pain. Additionally, conolidine seems to impact G protein-coupled receptor (GPCR) pathways integral to suffering perception. Com... https://laurab158uvt2.atualblog.com/profile